After stratification by tumor grade, CHD1L mRNA expression in grade II and grade III ovarian serous cystadenocarcinoma were significantly higher than normal ovarian tissue or grade I ovarian serous cystadenocarcinoma (Fig. 1B). This evidence concerns the gene CHD1L and ovarian serous cystadenocarcinoma.